Ajanta Pharma Q3 net up 20 Percent at Rs 111.3 crore
New Delhi : Ajanta Pharma reported a 19.60 per cent increase in consolidated net profit at Rs 111.3 crore for the quarter ended December 31, 2015.
The company had posted a net profit of Rs 93.06 crore for the same period of the previous fiscal.
Net sales of the company rose to Rs 465.71 crore for the December quarter, up 15.97 per cent from Rs 401.56 crore in the year-ago period, Ajanta Pharma said in a BSE filing.
"We have established strong sales and marketing network in select international markets which continue to perform well and generate demand for our branded generics.
"However, the currency devaluation and scarcity of forex availability in few emerging markets limited us to achieve our full potential," Ajanta Pharma Joint Managing Director Rajesh Agrawal said.
The company had posted a net profit of Rs 93.06 crore for the same period of the previous fiscal.
Net sales of the company rose to Rs 465.71 crore for the December quarter, up 15.97 per cent from Rs 401.56 crore in the year-ago period, Ajanta Pharma said in a BSE filing.
"We have established strong sales and marketing network in select international markets which continue to perform well and generate demand for our branded generics.
"However, the currency devaluation and scarcity of forex availability in few emerging markets limited us to achieve our full potential," Ajanta Pharma Joint Managing Director Rajesh Agrawal said.
Next Story